ASO Author Reflections: Can Perioperative Ghrelin Administration Inhibit Postoperative Muscle Mass Loss in Esophageal Cancer Patients?
- 15.02.2022
- ASO Author Reflections
Erschienen in:
- Verfasst von
- Yohei Nose, MD
- Kotaro Yamashita, MD, PhD
- Tomohira Takeoka, MD, PhD
- Kota Momose, MD, PhD
- Takuro Saito, MD, PhD
- Koji Tanaka, MD, PhD
- Kazuyoshi Yamamoto, MD, PhD
- Tomoki Makino, MD, PhD
- Tsuyoshi Takahashi, MD, PhD
- Yukinori Kurokawa, MD, PhD
- Makoto Yamasaki, MD, PhD
- Osamu Shiraishi, MD, PhD
- Hiroshi Miyata, MD, PhD
- Takushi Yasuda, MD, PhD
- Masahiko Yano, MD, PhD
- Hidetoshi Eguchi, MD, PhD
- Yuichiro Doki, MD, PhD
- Erschienen in
- Annals of Surgical Oncology | Ausgabe 6/2022
Auszug
Ghrelin is a gastrointestinal peptide produced mainly in the stomach in response to fasting, and is involved in multiple functions such as growth hormone (GH) secretion, stimulation of appetite, and a positive energy balance.1 We reported that serum ghrelin levels decrease after upper gastrointestinal cancer surgery,2 and that postoperative intermittent administration of ghrelin after the start of food intake suppresses postoperative weight loss by improving appetite and oral food intake in patients undergoing upper gastrointestinal surgery.3,4 However, effects of continuous intravenous administration of ghrelin during postoperative starvation on body weight and body composition have not been clarified. …
Anzeige
- Titel
- ASO Author Reflections: Can Perioperative Ghrelin Administration Inhibit Postoperative Muscle Mass Loss in Esophageal Cancer Patients?
- Verfasst von
-
Yohei Nose, MD
Kotaro Yamashita, MD, PhD
Tomohira Takeoka, MD, PhD
Kota Momose, MD, PhD
Takuro Saito, MD, PhD
Koji Tanaka, MD, PhD
Kazuyoshi Yamamoto, MD, PhD
Tomoki Makino, MD, PhD
Tsuyoshi Takahashi, MD, PhD
Yukinori Kurokawa, MD, PhD
Makoto Yamasaki, MD, PhD
Osamu Shiraishi, MD, PhD
Hiroshi Miyata, MD, PhD
Takushi Yasuda, MD, PhD
Masahiko Yano, MD, PhD
Hidetoshi Eguchi, MD, PhD
Yuichiro Doki, MD, PhD
- Publikationsdatum
- 15.02.2022
- Verlag
- Springer International Publishing
- Erschienen in
-
Annals of Surgical Oncology / Ausgabe 6/2022
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681 - DOI
- https://doi.org/10.1245/s10434-022-11437-z
Dieser Inhalt ist nur sichtbar, wenn du eingeloggt bist und die entsprechende Berechtigung hast.
